EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Drug interactions in a sample of inpatients diagnosed with cannabis use disorder

Martin Schulze Westhoff iD, Christina Massarou, Stefan Bleich iD, Johannes Heck iD, Konstantin Fritz Jendretzky iD, Alexander Glahn, Sebastian Schröder iD

Journal of Neural Transmission · 2025

DOI: 10.1007/s00702-025-02884-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neural Transmission, 2025. Verfasst von Martin Schulze Westhoff und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. Hauptthemen laut MEDLINE: Marijuana Abuse. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medizinische Hochschule Hannover (MHH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The majority of patients with cannabis use disorder (CUD) regularly take medication. Cannabinoids influence metabolism of some commonly prescribed drugs. However, little is known about the characteristics and frequency of potential cannabis-drug (CDIs) and drug-drug interactions (DDIs) in patients with CUD. Therefore, our study aimed to determine the prevalence and characteristics of drug interactions in patients with CUD during inpatient treatment on an addiction-specific ward over a six-year-period. To this aim, medication charts were analyzed and screened for potential CDIs and DDIs. Herein, the drugs.com classification for potential CDIs and UpToDate Lexicomp program for potential DDIs were utilized. The study cohort consisted of 301 patient cases, predominantly male (85.0%), with a median age of 37 years. 89.4% (269/301) of all cases involved were taking at least one drug that could potentially interact with cannabis. Levomethadone, buprenorphine and morphine were the most common drugs involved in potentially serious CDIs. In addition, 196 DDIs were identified, of which 25.5% were classified as ‘avoid combination’ and 74.5% as ‘consider therapy modification’. Hereby, combinations of levomethadone with other psychotropic drugs most frequently accounted for potentially severe and mild DDIs. The results of our study indicate that especially patients diagnosed with CUD also receiving opioid substitution therapy are at risk for potential drug interactions. Therefore, a clinical monitoring of vigilance and respiratory function should be applied during inpatient treatment. Routine use of interaction check tools in patients diagnosed with CUD should also be considered by healthcare providers. In addition, therapeutic drug monitoring (TDM) should be used to increase medication safety in this patient population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Marijuana AbuseHumansMaleAdultDrug InteractionsFemaleInpatientsMiddle AgedYoung AdultAnalgesics, Opioid

Stichwörter der Autor:innen

CannabisCannabis use disorderCannabis-drug interactionsDrug SafetyDrug-drug interactions

Substanzen

Analgesics, Opioid

Autor:innen und Institutionen

  • Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
  • Institute for Clinical Pharmacology, Hannover Medical School, Hannover, Germany.
  • Department of Neurology, Hannover Medical School, Hannover, Germany.
  • Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. schroeder.sebastian@mh-hannover.de.

ORCID-Profile: Martin Schulze Westhoff, Stefan Bleich, Johannes Heck, Konstantin Fritz Jendretzky, Sebastian Schröder

Förderung

  • Medizinische Hochschule Hannover (MHH)

Zitieren

APA

Schulze Westhoff, M., Massarou, C., Bleich, S., Heck, J., Jendretzky, K. F., Glahn, A., & Schröder, S. (2025). Drug interactions in a sample of inpatients diagnosed with cannabis use disorder. Journal of Neural Transmission. https://doi.org/10.1007/s00702-025-02884-5

Vancouver

Schulze Westhoff M, Massarou C, Bleich S, Heck J, Jendretzky KF, Glahn A, et al. Drug interactions in a sample of inpatients diagnosed with cannabis use disorder. Journal of Neural Transmission. 2025. doi:10.1007/s00702-025-02884-5

BibTeX
@article{SchulzeWesthoff2025,
  author = {Schulze Westhoff, Martin and Massarou, Christina and Bleich, Stefan and Heck, Johannes and Jendretzky, Konstantin Fritz and Glahn, Alexander and Schröder, Sebastian},
  title = {Drug interactions in a sample of inpatients diagnosed with cannabis use disorder},
  journal = {Journal of Neural Transmission},
  year = {2025},
  doi = {10.1007/s00702-025-02884-5}
}
Kostenlos starten →